Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

408 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GLUEMonte Rosa Therapeutics$8.64$761.36M-5.05-36.09%Strong BuyUnlock the GLUE analyst price target with TipRanks PremiumGLUEUnlock the GLUE top-analyst price target with TipRanks Premium
KURAKura Oncology$6.91$675.31M-2.09-37.07%Strong BuyUnlock the KURA analyst price target with TipRanks PremiumGLUE vs KURAUnlock the KURA top-analyst price target with TipRanks Premium
ARVNArvinas Holding Company$6.46$441.37M-43.07-41.38%Moderate BuyUnlock the ARVN analyst price target with TipRanks PremiumGLUE vs ARVNUnlock the ARVN top-analyst price target with TipRanks Premium
CCCCC4 Therapeutics$2.48$320.41M-3.444.20%Strong BuyUnlock the CCCC analyst price target with TipRanks PremiumGLUE vs CCCCUnlock the CCCC top-analyst price target with TipRanks Premium
ALMSAlumis Inc.$3.96$562.12M-1.14-42.77%Strong BuyUnlock the ALMS analyst price target with TipRanks PremiumGLUE vs ALMSUnlock the ALMS top-analyst price target with TipRanks Premium
ODTXOdyssey Therapeutics, Inc.$16.96$881.56M-4.573.29%Strong BuyUnlock the ODTX analyst price target with TipRanks PremiumGLUE vs ODTXUnlock the ODTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GLUEMonte Rosa Therapeutics8.64-5.58-39.24%
KURAKura Oncology6.91-4.26-38.14%
ARVNArvinas Holding Company6.46-5.06-43.92%
CCCCC4 Therapeutics2.480.041.64%
ALMSAlumis Inc.3.96-3.34-45.75%
ODTXOdyssey Therapeutics, Inc.16.960.543.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts